MedPath

The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs

Conditions
Covid19
Tonsillitis
Adenoiditis
Tonsil Hypertrophy
Adenoid Hypertrophy
Immune Deficiency
Registration Number
NCT04646525
Lead Sponsor
Selcuk University
Brief Summary

We aimed to find out whether the tonsils and nasal tissues of pediatric patients are the main factors that protects the children's immune system against COVID-19 infection.

Detailed Description

Since it is known that the tonsil and adenoid tissues that are known as a secondary lymphoid organ, which form the first line of defense, are more active in childhood than adults, especially in the childhood age group, and since it has been scientifically shown that patients diagnosed with COVID-19 infection in the pediatric age group overcome this disease lightly than adults, we aimed to reveal whether the defined tonsil and adenoid tissues are the main factors that protect the children's immune system against COVID-19 infection.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Patients with COVID-19 infection.
  • Patients aged between 1-16 years
  • Patients whose PCR test becomes negative
Exclusion Criteria
  • Patients with lymphoid tissue malignant disease
  • Patients with known lung disease
  • Patients with known systemic disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome of our study was the evaluation of pediatric patients diagnosed with COVID-19 and who had COVID-19 infection in terms of adenoid and tonsillar tissue hypertrophy and the presence of chronic or recurrent infection.2020-2021

The structure of the tonsil and adenoid tissues will be examined by physical examination, and the presence of tonsil and adenoid hypertrophy, tonsillitis, and adenoiditis conditions will be identified. The severity of covid-19 will be determined according to the cases of patients with tonsil and adenoid tissue disorders, who are hospitalized in intensive care, have infiltration in the lungs, and receive oxygen support.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Selcuk University

🇹🇷

Konya, Selcuklu, Turkey

© Copyright 2025. All Rights Reserved by MedPath